Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

Mutations in the NR3C1 gene cause a rare condition that affects hormone signaling and can lead to various symptoms, with dexamethasone as a treatment option.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Adipose stem cell-derived exosomes greatly improve wound healing.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Lactobacillus paracasei HY7015 helps hair grow in mice.

p21waf1/cip1 and p27kip1 help in hair follicle differentiation in rats.

CD44 signaling can help heal wounds without scars.

Pimecrolimus boosts melanin production and movement of skin pigment cells.

ADSC-derived extracellular vesicles show promise for skin and hair regeneration and wound healing.

Pine bark extract helps mice grow hair by reducing inflammation and boosting growth factors.

Certain bacteria from the Citrullus colocynthis plant may be a new source of antibiotics to fight drug-resistant diseases.

NFATc1 is crucial for keeping hair follicle stem cells inactive.

Topical corticosteroids are recommended first for treating pediatric alopecia areata due to their safety and ease of use.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

The substances improved hair regrowth and protected hair cells in humans and mice.

Smart hydrogel dressings could improve diabetic wound healing by adjusting to wound conditions and controlling drug release.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

Onion extracts can promote hair growth, but quercetin is not responsible.

Alopecia totalis/universalis is linked to more autoimmune diseases than patchy alopecia areata.

Improved CRBN ligands make protein degraders more effective and drug-like.

Microneedles offer a promising, less invasive way to treat and monitor psoriasis.

Phenobarbital-loaded chitosan nanoparticles are promising for preventing hair loss from chemotherapy.

New hair regrowth therapies show promise but need more research.